Literature DB >> 975729

Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients.

D R Stanski, D J Greenblatt, A Selwyn, R I Shader, K Franke, J Koch-Weser.   

Abstract

Thirty otherwise healthy patients received a 100-mg oral dose of chlordiazepoxide HCl just prior to surgical procedures using spinal anesthesia. Fourteen of these patients had also received 100 mg on the night before surgery. Simultaneous samples of venous blood and cerebrospinal fluid (CSF) were taken immediately prior to injection of spinal anesthesia and were assayed for concentrations of chlordiazepoxide (CDX) and its major metabolite, desmethylchlordiazepoxide. Plasma concentrations of CDX ranged from 2.32 to 13.34 mug/ml. Simultaneous CSF concentrations were considerably lower, ranging from 0.04 to 0.34 mug/ml. Equilibration of CDX between plasma and the lumbar sampling site appeared to be complete within 2 hr of the most recent dose. After attainment of distribution equilibrium, simultaneous plasma and CSF concentrations of CDX were hightly correlated (r = 0.76), with a mean CSF-plasma concentrations ratio of only 0.043 (range; 0.02 to 0.06). The limited passage of CDX into human CSF is probably due to extensive binding to plasma protein. Assuming that transfer of CDX from plasma to CSF is governed by passive diffusion, the extent of plasma protein binding of CDX in healthy individuals averages about 96%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975729     DOI: 10.1002/cpt1976205571

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Clinical pharmacology and therapeutics of benzodiazepines.

Authors:  E M Sellers
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

3.  CSF penetration and pharmacokinetics of midazolam.

Authors:  S Sjövall; J Kanto; J J Himberg; M Hovi-Viander; M Salo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 5.  Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

Authors:  Steven J Weintraub
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

Review 6.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

7.  Factors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysis.

Authors:  D J Greenblatt; J S Harmatz; D R Stanski; R I Shader; K Franke; J Koch-Weser
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

8.  The effects of benzodiazepine agonists, inverse agonists and Ro 15-1788 on the responses of the superior cervical ganglion to GABA in vitro.

Authors:  H J Little
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

9.  Entry of diazepam and its major matabolite into cerebrospinal fluid.

Authors:  D J Greenblatt; H R Ochs; B L Lloyd
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.